Remove Capital Remove Companies Remove Pricing Remove San Diego
article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 per share, raising just over $1 billion for the company. The company will begin trading this morning on the Nasdaq Global Select Market as TSP.

Pricing 113
article thumbnail

Avidity Biosciences Prices IPO

socalTECH

San Diego-based Avidity Bio , a biopharmaceuticals company working on oligonucleotide-based therapies, priced its IPO last night, saying that it will offer up 14,400,000 shares of its common stock at $18.00 The company priced above its initial estimated offering range of $14.00 READ MORE>>.

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Evofem Prices $50M Offering

socalTECH

San Diego-based Evofem Biosciences, which is developing biopharmaceuticals for women's contraception and related areas, says it has priced a $50M, public offering, and also will receive up to an additoinal $50M upon exercise of accompanying short-term warrant.

Pricing 113
article thumbnail

San Diego's Seismic Snags $100M, Joins Unicorns

socalTECH

San Diego-based Seismic , a developer of sales and marketing software, has raised $100M more in a funding round, which values the company at $1 billion, the company said on Tuesday. Rowe Price, plus General Atlantic, JMI Equity, and Jackson Square Ventures. READ MORE>>.

San Diego 113
article thumbnail

Odonate Therapeutics Prices IPO

socalTECH

San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 The $24.00 READ MORE>>.

Pricing 113
article thumbnail

Ignyta Prices IPO

socalTECH

San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 for the company. Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today. The IPO will raised $48.0M READ MORE>>.

Pricing 138
article thumbnail

Avidity Biosciences Ups Public Offering Size

socalTECH

San Diego-based biopharmaceuticals company Avidity Biosciences said on Thursday that it has upsized its public offering, and will be offering up 12,000,000 shares of its common stock at a price to the public of $17.25 per share, and is now expecting to raise $207M for the company.

San Diego 113